Obstructive sleep apnea

Contemporary Sleep Medicine For Physicians

Volumn , Issue , 2011, Pages 71-110

  Qamar, Arman ^a   Kotha, Kavitha S ^b   Ioachimescu, Octavian C ^b,c,d  

^a UNIVERSITY OF DELHI   (India)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875650259     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805153311101010071     Document Type: Chapter

References (304)

1. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976; 27: 465-84.
2. Epstein LJ, Kristo D, Strollo PJ, Jr., Friedman N, Malhotra A, Patil SP et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5(3): 263-76.
3. Broadbent WH. Cheyne Stokes respiration in cerebral hemorrhage. Lancet 1877; 3: 307-9.
4. Lavie P. Restless Nights: Understanding Snoring and Sleep Apnea. New Haven, CT: Yale University Press. 2003.
5. Lavie P. Nothing new under the moon. Historical accounts of sleep apnea syndrome. Arch Intern Med 1984; 144(10): 2025-8.
6. Cheyne J. A case of apoplexy in which the fleshy part of the heart was connected to fat. Dublin Hospital Report 1818; 2: 216-23.
7. Stokes W. The Diseases of the Heart and Aorta. Dublin: 1854.
8. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993; 328(17): 1230-5.
9. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165(9): 1217-39.
10. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991; 46(2): 85-90.
11. Jennum P, Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992; 1(4): 240-4.
12. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5(2): 136-43.
13. Bixler EO, Vgontzas AN, Ten HT, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157(1): 144-8.
14. Bixler EO, Vgontzas AN, Lin HM, Ten HT, Rein J, Vela-Bueno A, Kales A. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 608-13.
15. Bearpark H, Elliott L, Grunstein R, Cullen S, Schneider H, Althaus W, Sullivan C. Snoring and sleep apnea. A population study in Australian men. Am J Respir Crit Care Med 1995; 151(5): 1459-65.
16. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a populationbased sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 685-9.
17. Ip MS, Lam B, Lauder IJ, Tsang KW, Chung KF, Mok YW, Lam WK. A community study of sleep-disordered breathing n middle-aged Chinese men in Hong Kong. Chest 2001; 119(1): 62-9.
18. Ip MS, Lam B, Tang LC, Lauder IJ, Ip TY, Lam WK. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest 2004; 125(1): 127-34.
19. Udwadia ZF, Doshi AV, Lonkar SG, Singh CI. Prevalence of sleep-disordered breathing and sleep apnea in middle-aged urban Indian men. Am J Respir Crit Care Med 2004; 169(2): 168-73.
20. Puvanendran K, Goh KL. From snoring to sleep apnea in a Singapore population. Sleep Res Online 1999; 2(1): 11-4.
21. Gislason T, Almqvist M, Eriksson G, Taube A, Boman G. Prevalence of sleep apnea syndrome among Swedish men--an epidemiological study. J Clin Epidemiol 1988; 41(6): 571-6.
22. Tishler PV, Larkin EK, Schluchter MD, Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003; 289(17): 2230-7.
23. Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998; 157(1): 111-5.
24. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19(12): 2271-7.
25. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342(19): 1378-84.
26. Andreas S, Schulz R, Werner GS, Kreuzer H. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 1996; 7(7): 541-5.
27. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163(1): 19-25.
28. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middleaged men and women. Sleep 1997; 20(9): 705-6.
29. Kapur V, Strohl KP, Redline S, Iber C, O'Connor G, Nieto J. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 2002; 6(2): 49-54.
30. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995; 18(6): 425-32.
31. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in communitydwelling elderly. Sleep 1991; 14(6): 486-95.
32. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291(16): 2013-6.
33. Obesity and overweight, 2006. World Health Organization. Available online at: www.who.int/mediacentre/factsheets/fs311/en/index.html.
34. Obesity in US Adults: 2007. American Obesity Association. 2007. Available online at: http://www.obesity.org/statistics/.
35. Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis 1990; 141(5 Pt 1): 1228-31.
36. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993; 17(9): 533-40.
37. Davies RJ, Stradling JR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J 1990; 3(5): 509-14.
38. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47(2): 101-5.
39. Hoffstein V, Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992; 5(4): 377-81.
40. Levinson PD, McGarvey ST, Carlisle CC, Eveloff SE, Herbert PN, Millman RP. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993; 103(5): 1336-42.
41. Millman RP, Carlisle CC, McGarvey ST, Eveloff SE, Levinson PD. Body fat distribution and sleep apnea severity in women. Chest 1995; 107(2): 362-6.
42. Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993; 148(2): 462-6.
43. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241(1): 11-8.
44. Ferini-Strambi L, Zucconi M, Palazzi S, Castronovo V, Oldani A, Della MG, Smirne S. Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device. Chest 1994; 105(6): 1759-64.
45. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154(1): 50-9.
46. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. Prevalence. Am J Respir Crit Care Med 1995; 152(2): 711-6.
47. Jennum P, Hein HO, Suadicani P, Gyntelberg F. Cardiovascular risk factors in snorers. A cross-sectional study of 3,323 men aged 54 to 74 years: the Copenhagen Male Study. Chest 1992; 102(5): 1371-6.
48. Jennum P, Sjol A. Snoring, sleep apnoea and cardiovascular risk factors: the MONICA II Study. Int J Epidemiol 1993; 22(3): 439-44.
49. Schmidt-Nowara WW, Coultas DB, Wiggins C, Skipper BE, Samet JM. Snoring in a Hispanic-American population. Risk factors and association with hypertension and other morbidity. Arch Intern Med 1990; 150(3): 597-601.
50. Bliwise DL. Epidemiology of age-dependence in sleep disordered breathing (SDB) in old age: The Bay Area Sleep Cohort (BASC). Sleep Med Clin 2009; 4(1): 57-64.
51. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg 2003; 13(5): 676-83.
52. O'Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004; 14(1): 23-6.
53. Bae C, Schauer P, Chand B, Ioachimescu OC, Foldvary-Schaefer N. Clinical and polysomnographic features of bariatric surgery candidates with suspected sleep apnea. Sleep 29[Abstract Supplement], A215. 2006.
54. Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J 2009; 33(4): 907-14.
55. Flemons WW. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002; 347(7): 498-504.
56. Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151(3 Pt 1): 688-91.
57. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 1995; 122(3): 174-8.
58. Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151(3 Pt 1): 682-7.
59. Ovchinsky A, Rao M, Lotwin I, Goldstein NA. The familial aggregation of pediatric obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 2002; 128(7): 815-8.
60. Carmelli D, Bliwise DL, Swan GE, Reed T. Genetic factors in self-reported snoring and excessive daytime sleepiness: a twin study. Am J Respir Crit Care Med 2001; 164(6): 949-52.
61. Jennum P, Hein HO, Suadicani P, Sorensen H, Gyntelberg F. Snoring, family history, and genetic markers in men. The Copenhagen Male Study. Chest 1995; 107(5): 1289-93.
62. Riha RL, Gislasson T, Diefenbach K. The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J 2009; 33(3): 646-55.
63. Palmer LJ, Buxbaum SG, Larkin E, Patel SR, Elston RC, Tishler PV, Redline S. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003; 72(2): 340-50.
64. Palmer LJ, Buxbaum SG, Larkin EK, Patel SR, Elston RC, Tishler PV, Redline S. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004; 169(12): 1314-21.
65. Patel SR, Larkin EK, Redline S. Shared genetic basis for obstructive sleep apnea and adiposity measures. Int J Obes (Lond) 2008; 32(5): 795-800.
66. Schwab RJ, Pasirstein M, Kaplan L, Pierson R, Mackley A, Hachadoorian R et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med 2006; 173(4): 453-63.
67. Li KK, Powell NB, Kushida C, Riley RW, Adornato B, Guilleminault C. A comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope 1999; 109(12): 1937-40.
68. Lam B, Ip MS, Tench E, Ryan CF. Craniofacial profile in Asian and white subjects with obstructive sleep apnoea. Thorax 2005; 60(6): 504-10.
69. Wellman A, Jordan AS, Malhotra A, Fogel RB, Katz ES, Schory K et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170(11): 1225-32.
70. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154(19): 2219-24.
71. Lavie L, Lavie P. Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 2008; 9(3): 247-53.
72. Mitler MM, Dawson A, Henriksen SJ, Sobers M, Bloom FE. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988; 12(6): 801-5.
73. Berry RB, Bonnet MH, Light RW. Effect of ethanol on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 1992; 145(2 Pt 1): 445-52.
74. Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000; 16(5): 909-13.
75. Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 2009; 51(4): 285-93.
76. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997; 99(2): S757-S762.
77. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31(8): 1079-85.
78. McNicholas WT, Tarlo S, Cole P, Zamel N, Rutherford R, Griffin D, Phillipson EA. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126(4): 625-8.
79. Mirza N, Lanza DC. The nasal airway and obstructed breathing during sleep. Otolaryngol Clin North Am 1999; 32(2): 243-62.
80. White DP. The pathogenesis of obstructive sleep apnea: advances in the past 100 years. Am J Respir Cell Mol Biol 2006; 34(1): 1-6.
81. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86(3): 1175-80.
82. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001; 86(2): 517-20.
83. Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santen RJ et al. Influence of testosterone on breathing during sleep. J Appl Physiol 1986; 61(2): 618-23.
84. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003; 88(8): 3605-13.
85. Winkelman JW, Goldman H, Piscatelli N, Lukas SE, Dorsey CM, Cunningham S. Are thyroid function tests necessary in patients with suspected sleep apnea? Sleep 1996; 19(10): 790-3.
86. Lanfranco F, Motta G, Minetto MA, Baldi M, Balbo M, Ghigo E et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol 2010; 2010: 474518.
87. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991; 115(7): 527-32.
88. Fatti LM, Scacchi M, Pincelli AI, Lavezzi E, Cavagnini F. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 2001; 4(4): 259-62.
89. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004; 151(4): 439-46.
90. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study. Mayo Clin Proc 2001; 76(9): 897-905.
91. Kaw R, Golish J, Ghamande S, Burgess R, Foldvary N, Walker E. Incremental risk of obstructive sleep apnea on cardiac surgical outcomes. J Cardiovasc Surg (Torino) 2006; 47(6): 683-9.
92. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999; 92(2): 79-84.
93. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999; 14(1): 179-84.
94. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352(12): 1206-14.
95. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172(11): 1447-51.
96. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353(19): 2034-41.
97. Krieger J, Sforza E, Apprill M, Lampert E, Weitzenblum E, Ratomaharo J. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989; 96(4): 729-37.
98. Ambrosetti M, Lucioni A, Ageno W, Conti S, Neri M. Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost 2004; 2(10): 1858-60.
99. Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 2008; 4(3): 261-72.
100. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160(6): 521-30.
101. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365(9464): 1046-53.
102. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283(14): 1829-36.
103. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 2000; 284(23): 3015-21.
104. Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001; 2(6): 477-91.
105. Engleman HM, Douglas NJ. Sleep, driving and the workplace. Clin Med 2005; 5(2): 113-7.
106. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004; 27(3): 453-8.
107. Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001; 164(11): 2031-5.
108. Saunamaki T, Jehkonen M. A review of executive functions in obstructive sleep apnea syndrome. Acta Neurol Scand 2007; 115(1): 1-11.
109. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31(8): 1071-8.
110. Wenner JB, Cheema R, Ayas NT. Clinical manifestations and consequences of obstructive sleep apnea. J Cardiopulm Rehabil Prev 2009; 29(2): 76-83.
111. Cluydts R, De VE, Verstraeten E, Theys P. Daytime sleepiness and its evaluation. Sleep Med Rev 2002; 6(2): 83-96.
112. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14(6): 540-5.
113. Ramachandran SK, Josephs LA. A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 2009; 110(4): 928-39.
114. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131(7): 485-91.
115. Nuckton TJ, Glidden DV, Browner WS, Claman DM. Physical examination: Mallampati score as an independent predictor of obstructive sleep apnea. Sleep 2006; 29(7): 903-8.
116. Waite PD. Obstructive sleep apnea: a review of the pathophysiology and surgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85(4): 352-61.
117. Ioachimescu OC. The diagnosis and severity of obstructive sleep apnea (OSA): a comprehensive analysis of different predictive models. Sleep (APSS), Minneapolis, June 2007 (Personal Communication).
118. Netzer N, Eliasson AH, Netzer C, Kristo DA. Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest 2001; 120(2): 625-33.
119. ICSD-2 - The International Classification of Sleep Disorders - Diagnostic and Coding Manual. Second Edition ed. Westchester,IL: American Academy of Sleep Medicine. 2005.
120. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM Manual for the Scoring of Sleep and Associated Events - Rules, Terminology and Technical Specifications. 1 ed. Westchester, IL: American Academy of Sleep Medicine. 2007.
121. Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007; 3(7): 737-47.
122. Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28(1): 113-21.
123. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB. The clinical use of the MSLT and MWT. Sleep 2005; 28(1): 123-44.
124. Bonnet MH. ACNS clinical controversy: MSLT and MWT have limited clinical utility. J Clin Neurophysiol 2006; 23(1): 50-8.
125. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007; 30(4): 519-29.
126. Bonnet MH, Arand DL. We are chronically sleep deprived. Sleep 1995; 18(10): 908-11.
127. Guilleminault C, Rosekind M. The arousal threshold: sleep deprivation, sleep fragmentation, and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 1981; 17(3): 341-9.
128. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the control of ventilation. Am Rev Respir Dis 1983; 128(6): 984-6.
129. Bowes G, Woolf GM, Sullivan CE, Phillipson EA. Effect of sleep fragmentation on ventilatory and arousal responses of sleeping dogs to respiratory stimuli. Am Rev Respir Dis 1980; 122(6): 899-908.
130. Series F, Cormier Y, La FJ, Desmeules M. Mechanisms of the effectiveness of continuous positive airway pressure in obstructive sleep apnea. Sleep 1992; 15(6 Suppl): S47-S49.
131. Koenig JS, Thach BT. Effects of mass loading on the upper airway. J Appl Physiol 1988; 64(6): 2294-9.
132. Wolin AD, Strohl KP, Acree BN, Fouke JM. Responses to negative pressure surrounding the neck in anesthetized animals. J Appl Physiol 1990; 68(1): 154-60.
133. Winter WC, Gampper T, Gay SB, Suratt PM. Lateral pharyngeal fat pad pressure during breathing. Sleep 1996; 19(10 Suppl): S178-S179.
134. Hoffstein V, Mateika S. Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med 1994; 150(2): 486-8.
135. Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154(3 Pt 1): 806-12.
136. Schwab RJ, Gefter WB, Pack AI, Hoffman EA. Dynamic imaging of the upper airway during respiration in normal subjects. J Appl Physiol 1993; 74(4): 1504-14.
137. Schwab RJ, Gefter WB, Hoffman EA, Gupta KB, Pack AI. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis 1993; 148(5): 1385-400.
138. Winter WC, Gampper T, Gay SB, Suratt PM. Enlargement of the lateral pharyngeal fat pad space in pigs increases upper airway resistance. J Appl Physiol 1995; 79(3): 726-31.
139. Harman EM, Wynne JW, Block AJ. The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982; 82(3): 291-4.
140. Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004; 5(2): 125-31.
141. Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S, Smith PL. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991; 144(3 Pt 1): 494-8.
142. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103(6 ( Pt 1)): 850-5.
143. Suratt PM, McTier RF, Findley LJ, Pohl SL, Wilhoit SC. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest 1987; 92(4): 631-7.
144. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292(14): 1724-37.
145. Frey WC, Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg 2003; 13(5): 676-83.
146. O'Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004; 14(1): 23-6.
147. Fernandez AZ, Jr., DeMaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, Sugerman HJ. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc 2004; 18(2): 193-7.
148. Perugini RA, Mason R, Czerniach DR, Novitsky YW, Baker S, Litwin DE, Kelly JJ. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg 2003; 138(5): 541-5.
149. Phillips BA, Danner FJ. Cigarette smoking and sleep disturbance. Arch Intern Med 1995; 155(7): 734-7.
150. Gothe B, Strohl KP, Levin S, Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 1985; 87(1): 11-7.
151. Berry RB, Desa MM, Light RW. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1991; 99(2): 339-43.
152. Gleeson K, Zwillich CW, White DP. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 1990; 142(2): 295-300.
153. Roehrs T, Beare D, Zorick F, Roth T. Sleepiness and ethanol effects on simulated driving. Alcohol Clin Exp Res 1994; 18(1): 154-8.
154. Teschler H, Berthon-Jones M, Wessendorf T, Meyer HJ, Konietzko N. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy. Eur Respir J 1996; 9(11): 2371-7.
155. Kohler M, Bloch KE, Stradling JR. Pharmacological approaches to the treatment of obstructive sleep apnoea. Expert Opin Investig Drugs 2009; 18(5): 647-56.
156. Espinoza H, Antic R, Thornton AT, McEvoy RD. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1987; 136(1): 80-4.
157. Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest 1992; 101(3): 753-7.
158. Whyte KF, Gould GA, Airlie MA, Shapiro CM, Douglas NJ. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 11(5): 463-72.
159. Atkinson RL, Suratt PM, Wilhoit SC, Recant L. Naloxone improves sleep apnea in obese humans. Int J Obes 1985; 9(4): 233-9.
160. Ferber C, Duclaux R, Mouret J. Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep. J Sleep Res 1993; 2(3): 149-55.
161. Cook WR, Benich JJ, Wooten SA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989; 96(2): 262-6.
162. Hudgel DW, Hendricks C, Dadley A. Alteration in obstructive apnea pattern induced by changes in oxygen- and carbondioxide-inspired concentrations. Am Rev Respir Dis 1988; 138(1): 16-9.
163. Villiger PM, Hess CW, Reinhart WH. Beneficial effect of inhaled CO2 in a patient with non-obstructive sleep apnoea. J Neurol 1993; 241(1): 45-8.
164. Badr MS, Grossman JE, Weber SA. Treatment of refractory sleep apnea with supplemental carbon dioxide. Am J Respir Crit Care Med 1994; 150(2): 561-4.
165. Sunderram J, Parisi RA, Strobel RJ. Serotonergic stimulation of the genioglossus and the response to nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162(3 Pt 1): 925-9.
166. Carley DW, Olopade C, Ruigt GS, Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 2007; 30(1): 35-41.
167. Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003; 168(10): 1246-51.
168. Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest 2008; 133(3): 677-83.
169. Hedner J, Kraiczi H, Peker Y. Reducation of sleep apnea after orally available cholinesterase inhibitor donepezil. Sleep Med 6, S54-S55. 2005.
170. Marshall NS, Yee BJ, Desai AV, Buchanan PR, Wong KK, Crompton R et al. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 2008; 31(6): 824-31.
171. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22(1): 61-7.
172. Stradling J, Smith D, Radulovacki M, Carley D. Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial. J Sleep Res 2003; 12(2): 169-70.
173. Veasey SC, Chachkes J, Fenik P, Hendricks JC. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001; 24(2): 155-60.
174. Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 1998; 84(3): 1055-62.
175. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003; 26(2): 163-8.
176. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoffmann R, Peter JH. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991; 78(2): 124-30.
177. Salo TM, Kantola I, Voipio-Pulkki LM, Pelttari L, Viikari JS. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability. Eur J Clin Pharmacol 1999; 55(3): 191-8.
178. Salo TM, Metsala TH, Kantola IM, Jalonen JO, Voipio-Pulkki LM, Valimaki IA, Viikari JS. Ramipril Enhances Autonomic Control in Essential Hypertension: A Study Employing Spectral Analysis of Heart Rate Variation. Am J Ther 1994; 1(3): 191-7.
179. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with coexisting rhinitis. Thorax 2004; 59(1): 50-5.
180. Clarenbach CF, Kohler M, Senn O, Thurnheer R, Bloch KE. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res 2008; 17(4): 444-9.
181. Morrell MJ, Arabi Y, Zahn BR, Meyer KC, Skatrud JB, Badr MS. Effect of surfactant on pharyngeal mechanics in sleeping humans: implications for sleep apnoea. Eur Respir J 2002; 20(2): 451-7.
182. Jokic R, Klimaszewski A, Mink J, Fitzpatrick MF. Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial. Am J Respir Crit Care Med 1998; 157(5 Pt 1): 1522-5.
183. Martin RJ, Sanders MH, Gray BA, Pennock BE. Acute and long-term ventilatory effects of hyperoxia in the adult sleep apnea syndrome. Am Rev Respir Dis 1982; 125(2): 175-80.
184. Gold AR, Schwartz AR, Bleecker ER, Smith PL. The effect of chronic nocturnal oxygen administration upon sleep apnea. Am Rev Respir Dis 1986; 134(5): 925-9.
185. Strollo PJ, Jr. Indications for treatment of obstructive sleep apnea in adults. Clin Chest Med 2003; 24(2): 307-13, vii.
186. Sanders MH, Rogers RM. Sleep apnea: when does better become benefit? Chest 1985; 88(3): 320-1.
187. Hanly P, Sasson Z, Zuberi N, Lunn K. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993; 71(15): 1341-5.
188. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995; 345(8957): 1085-7.
189. Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest 1990; 98(2): 317-24.
190. Piper AJ, Sullivan CE. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105(2): 434-40.
191. Chauncey JB, Aldrich MS. Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep 1990; 13(2): 167-74.
192. Farney RJ, Walker JM, Elmer JC, Viscomi VA, Ord RJ. Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea. Chest 1992; 101(5): 1228-35.
193. Pepin JL, Viot-Blanc V, Escourrou P, Racineux JL, Sapene M, Levy P et al. Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J 2009; 33(5): 1062-7.
194. Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 2006; 29(8): 1031-5.
195. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006; 29(8): 1036-44.
196. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 2005; 28(4): 464-71.
197. Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebocontrolled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001; 163(4): 918-23.
198. Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164(9): 1675-81.
199. Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest 2003; 124(6): 2192-9.
200. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, doubleblind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006; 28(5): 689-706.
201. Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007; 101(3): 616-27.
202. Hou RH, Langley RW, Szabadi E, Bradshaw CM. Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers. J Psychopharmacol 2007; 21(6): 567-78.
203. Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC, Grebow PE. A double-blind, placebocontrolled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999; 39(1): 30-40.
204. Lavie P, Fischel N, Zomer J, Eliaschar I. The effects of partial and complete mechanical occlusion of the nasal passages on sleep structure and breathing in sleep. Acta Otolaryngol 1983; 95(1-2): 161-6.
205. Suratt PM, Turner BL, Wilhoit SC. Effect of intranasal obstruction on breathing during sleep. Chest 1986; 90(3): 324-9.
206. Hoijer U, Ejnell H, Hedner J, Petruson B, Eng LB. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 1992; 118(3): 281-4.
207. Hoffstein V, Mateika S, Metes A. Effect of nasal dilation on snoring and apneas during different stages of sleep. Sleep 1993; 16(4): 360-5.
208. Scharf MB, Brannen DE, McDannold M. A subjective evaluation of a nasal dilator on sleep & snoring. Ear Nose Throat J 1994; 73(6): 395-401.
209. Scharf MB, McDannold MD, Zaretsky NT, Hux GT, Brannen DE, Berkowitz DV. Cyclic alternating pattern sequences in non-apneic snorers with and without nasal dilation. Ear Nose Throat J 1996; 75(9): 617-9.
210. Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 1999; 11(3): 487-508.
211. Afzelius LE, Elmqvist D, Hougaard K, Laurin S, Nilsson B, Risberg AM. Sleep apnea syndrome--an alternative treatment to tracheostomy. Laryngoscope 1981; 91(2): 285-91.
212. Nahmias JS, Karetzky MS. Treatment of the obstructive sleep apnea syndrome using a nasopharyngeal tube. Chest 1988; 94(6): 1142-7.
213. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225): 862-5.
214. Grunstein RR. Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax 1995; 50(10): 1106-13.
215. Grunstein RR, Hedner J, Grote L. Treatment options for sleep apnoea. Drugs 2001; 61(2): 237-51.
216. McDaid C, Duree KH, Griffin SC, Weatherly HL, Stradling JR, Davies RJ et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009; 13(6): 427-36.
217. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003; 163(5): 565-71.
218. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; 3: CD001106.
219. Reeves-Hoche MK, Hudgel DW, Meck R, Witteman R, Ross A, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151(2 Pt 1): 443-9.
220. Fietze I, Glos M, Moebus I, Witt C, Penzel T, Baumann G. Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration 2007; 74(3): 279-86.
221. Nussbaumer Y, Bloch KE, Genser T, Thurnheer R. Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnea. Chest 2006; 129(3): 638-43.
222. Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001; 7(6): 391-8.
223. Fitzpatrick MF, Alloway CE, Wakeford TM, MacLean AW, Munt PW, Day AG. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure? Am J Respir Crit Care Med 2003; 167(5): 716-22.
224. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154(1): 182-6.
225. Wiest GH, Harsch IA, Fuchs FS, Kitzbichler S, Bogner K, Brueckl WM et al. Initiation of CPAP therapy for OSA: does prophylactic humidification during CPAP pressure titration improve initial patient acceptance and comfort? Respiration 2002; 69(5): 406-12.
226. Mador MJ, Krauza M, Pervez A, Pierce D, Braun M. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 2005; 128(4): 2151-8.
227. Nilius G, Happel A, Domanski U, Ruhle KH. Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance. Chest 2006; 130(4): 1018-24.
228. Fromm RE, Jr., Varon J, Lechin AE, Hirshkowitz M. CPAP machine performance and altitude. Chest 1995; 108(6): 1577-80.
229. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med 1994; 150(6 Pt 1): 1738-45.
230. McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H. A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176(2): 194-200.
231. McGinley B, Halbower A, Schwartz AR, Smith PL, Patil SP, Schneider H. Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics 2009; 124(1): 179-88.
232. Montserrat JM, Ballester E, Olivi H, Reolid A, Lloberes P, Morello A, Rodriguez-Roisin R. Time-course of stepwise CPAP titration. Behavior of respiratory and neurological variables. Am J Respir Crit Care Med 1995; 152(6 Pt 1): 1854-9.
233. Meurice JC, Paquereau J, Denjean A, Patte F, Series F. Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998; 11(5): 1121-7.
234. Issa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1986; 63(1): 10-7.
235. Condos R, Norman RG, Krishnasamy I, Peduzzi N, Goldring RM, Rapoport DM. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med 1994; 150(2): 475-80.
236. Jokic R, Klimaszewski A, Sridhar G, Fitzpatrick MF. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998; 114(4): 1061-9.
237. Miljeteig H, Hoffstein V. Determinants of continuous positive airway pressure level for treatment of obstructive sleep apnea. Am Rev Respir Dis 1993; 147(6 Pt 1): 1526-30.
238. Sanders MH, Kern NB, Costantino JP, Stiller RA, Studnicki K, Coates J et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis 1993; 147(5): 1169-74.
239. McArdle N, Grove A, Devereux G, Mackay-Brown L, Mackay T, Douglas NJ. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 2000; 15(4): 670-5.
240. Littner M, Hirshkowitz M, Davila D, Anderson WM, Kushida CA, Woodson BT et al. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 2002; 25(2): 143-7.
241. Morgenthaler TI, Aurora RN, Brown T, Zak R, Alessi C, Boehlecke B et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report. Sleep 2008; 31(1): 141-7.
242. Krieger J, Sforza E, Petiau C, Weiss T. Simplified diagnostic procedure for obstructive sleep apnoea syndrome: lower subsequent compliance with CPAP. Eur Respir J 1998; 12(4): 776-9.
243. White DP, Gibb TJ. Evaluation of the Healthdyne NightWatch system to titrate CPAP in the home. Sleep 1998; 21(2): 198-204.
244. Juhasz J, Schillen J, Urbigkeit A, Ploch T, Penzel T, Peter JH. Unattended continuous positive airway pressure titration. Clinical relevance and cardiorespiratory hazards of the method. Am J Respir Crit Care Med 1996; 154(2 Pt 1): 359-65.
245. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994; 150(5 Pt 1): 1279-85.
246. Ioachimescu O, Bedford T, Stephenson L., Foldvary-Schaefer N., Golish J. A Large Cohort Validation of CPAP Setting Predictions Based on Demographic, Anthropometric and Polysomnographic Data. Am J Respir Crit Care Med 2007; 175: A708.
247. Ioachimescu O, Bedford T, Bae C, Foldvary-Schaefer N, AL, Golish J. Continuous positive airway pressure (CPAP) level in obstructive sleep apnea (OSA): the aftermath of various mathematical models. Sleep 2006; 28: 456.
248. Ioachimescu OC, Bedford T, Stephenson L., Foldvary-Schaefer N, Golish J. A Large Cohort Validation of CPAP Setting Predictions Based on Demographic, Anthropometric and Polysomnographic Data. Am J.Respir.Crit Care Med 2007; 175[Suppl]: A708.
249. Ioachimescu OC, Bedford T, Bae C, Foldvary-Schaefer N, Aboussouan L, Golish J. Continuous positive airway pressure (CPAP) level in obstructive sleep apnea (OSA): the aftermath of various mathematical models. Sleep 2006; 29[Suppl]: A203.
250. Hoffstein V, Szalai JP. Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep 1993; 16(2): 118-22.
251. Hoffstein V, Mateika S. Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med 1994; 150(2): 486-8.
252. Hoffstein V. Accuracy of CPAP predicted from anthropometric and polysomnographic indices. Sleep 1997; 20(3): 237-8.
253. Lin IF, Chuang ML, Liao YF, Chen NH, Li HY. Predicting effective continuous positive airway pressure in Taiwanese patients with obstructive sleep apnea syndrome. J Formos Med Assoc 2003; 102(4): 215-21.
254. Masa JF, Jimenez A, Duran J, Capote F, Monasterio C, Mayos M et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004; 170(11): 1218-24.
255. Fitzpatrick MF, Alloway CE, Wakeford TM, MacLean AW, Munt PW, Day AG. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure? Am J Respir Crit Care Med 2003; 167(5): 716-22.
256. Stradling JR, Hardinge M, Paxton J, Smith DM. Relative accuracy of algorithm-based prescription of nasal CPAP in OSA. Respir Med 2004; 98(2): 152-4.
257. Stradling JR, Hardinge M, Smith DM. A novel, simplified approach to starting nasal CPAP therapy in OSA. Respir Med 2004; 98(2): 155-8.
258. Rowley JA, Tarbichi AG, Badr MS. The use of a predicted CPAP equation improves CPAP titration success. Sleep Breath 2005; 9(1): 26-32.
259. Zeng Y, Zhong N. [Prediction of the level of continuous positive airway pressure in the management of obstructive sleep apnea syndrome via nasal mask]. Zhonghua Jie He He Hu Xi Za Zhi 1996; 19(5): 269-72.
260. Viner S, Szalai JP, Hoffstein V. Are history and physical examination a good screening test for sleep apnea? Ann Intern Med 1991; 115(5): 356-9.
261. Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR et al. A survey screen for prediction of apnea. Sleep 1995; 18(3): 158-66.
262. Roche N, Herer B, Roig C, Huchon G. Prospective testing of two models based on clinical and oximetric variables for prediction of obstructive sleep apnea Chest 2002; 121(3): 747-52.
263. Ioachimescu OC, Bedford T. Aftermath of optimal CPAP prediction models using various linear, logistic regression and artificial neural networks (ANN) in OSA. Eur.Respir J. 2010; 36(Suppl 54):P975.
264. El Solh A, Akinnusi M, Patel A, Bhat A, TenBrock R. Predicting optimal CPAP by neural network reduces titration failure: a randomized study. Sleep Breath 2009; 13(4): 325-30.
265. Lamphere J, Roehrs T, Wittig R, Zorick F, Conway WA, Roth T. Recovery of alertness after CPAP in apnea. Chest 1989; 96(6): 1364-7.
266. Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999; 115(3): 863-6.
267. Holty JE, Guilleminault C. Surgical options for the treatment of obstructive sleep apnea. Med Clin North Am 2010; 94(3): 479-515.
268. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005;(4): CD001004.
269. Lojander J, Maasilta P, Partinen M, Brander PE, Salmi T, Lehtonen H. Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome. A randomized study. Chest 1996; 110(1): 114-9.
270. Woodson BT, Steward DL, Weaver EM, Javaheri S. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg 2003; 128(6): 848-61.
271. Brown DJ, Kerr P, Kryger M. Radiofrequency tissue reduction of the palate in patients with moderate sleep-disordered breathing. J Otolaryngol 2001; 30(4): 193-8.
272. Woodson BT, Nelson L, Mickelson S, Huntley T, Sher A. A multi-institutional study of radiofrequency volumetric tissue reduction for OSAS. Otolaryngol Head Neck Surg 2001; 125(4): 303-11.
273. Pazos G, Mair EA. Complications of radiofrequency ablation in the treatment of sleep-disordered breathing. Otolaryngol Head Neck Surg 2001; 125(5): 462-6.
274. Terris DJ, Chen V. Occult mucosal injuries with radiofrequency ablation of the palate. Otolaryngol Head Neck Surg 2001; 125(5): 468-72.
275. Khan A, Ramar K, Maddirala S, Friedman O, Pallanch JF, Olson EJ. Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: the mayo clinic experience. Mayo Clin Proc 2009; 84(9): 795-800.
276. Mortimore IL, Bradley PA, Murray JA, Douglas NJ. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996; 154(6 Pt 1): 1759-62.
277. Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163(6): 1457-61.
278. Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002; 166(5): 743-8.
279. Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA. Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Med Rev 2004; 8(6): 443-57.
280. Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29(2): 244-62.
281. Gagnadoux F, Fleury B, Vielle B, Petelle B, Meslier N, N'Guyen XL et al. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J 2009; 34(4): 914-20.
282. Hoekema A, Stegenga B, Bakker M, Brouwer WH, de Bont LG, Wijkstra PJ, van der Hoeven JH. Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath 2007; 11(3): 129-38.
283. Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, Pierce RJ. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170(6): 656-64.
284. Andren A, Sjoquist M, Tegelberg A. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance - a three-year follow-up. J Oral Rehabil 2009; 36(10): 719-25.
285. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18(6): 501-10.
286. Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA. Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 2001; 120(1): 162-9.
287. Marklund M, Stenlund H, Franklin KA. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 2004; 125(4): 1270-8.
288. Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev 2006;(1): CD004435.
289. Tsuiki S, Kobayashi M, Namba K, Oka Y, Komada Y, Kagimura T, Inoue Y. Optimal positive airway pressure predicts oral appliance response to sleep apnoea. Eur Respir J 2010; 35(5): 1098-105.
290. Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002; 121(3): 739-46.
291. Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999; 22(2): 237-40.
292. Rose EC, Staats R, Virchow C, Jr., Jonas IE. Occlusal and skeletal effects of an oral appliance in the treatment of obstructive sleep apnea. Chest 2002; 122(3): 871-7.
293. Almeida FR, Lowe AA, Otsuka R, Fastlicht S, Farbood M, Tsuiki S. Long-term sequellae of oral appliance therapy in obstructive sleep apnea patients: Part 2. Study-model analysis. Am J Orthod Dentofacial Orthop 2006; 129(2): 205-13.
294. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997; 276(5316): 1265-8.
295. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996; 271(5246): 216-9.
296. Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, Bleecker ER. Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis 1983; 127(2): 221-6.
297. Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med 1995; 152(5 Pt 1): 1673-89.
298. Remmers JE, Anch AM, deGroot WJ, Baker JP, Jr., Sauerland EK. Oropharyngeal muscle tone in obstructive sleep apnea before and after strychnine. Sleep 1980; 3(3-4): 447-53.
299. Isono S, Feroah TR, Hajduk EA, Brant R, Whitelaw WA, Remmers JE. Interaction of cross-sectional area, driving pressure, and airflow of passive velopharynx. J Appl Physiol 1997; 83(3): 851-9.
300. Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 1988; 64(2): 789-95.
301. Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007; 132(1): 325-37.
302. Gold AR, Schwartz AR. The pharyngeal critical pressure. The whys and hows of using nasal continuous positive airway pressure diagnostically. Chest 1996; 110(4): 1077-88.
303. Fogel RB, Malhotra A, White DP. Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004; 59(2): 159-63.
304. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90(1): 47-112.